Rebecca Ashare

University of Pennsylvania

NIH Rank #5542
  • Program Leader
  • R01 Holder
  • Multi-Institutional
  • Early Career

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#5,542
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 5 grants · National rank #5542.

Top grants by award amount

Rebecca Ashare's NIH grant portfolio, ranked by award amount.

  • 7R01CA285331-02R01
    Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV
    $675.1K
    award amount
  • 5R01CA270483-03R01
    Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study
    $620.3K
    award amount
  • 5U01CA286811-02U01
    Assessing benefits and harms of cannabis use in patients treated with immunotherapy for cancer: a prospective cohort study
    $599.4K
    award amount
  • 3R01CA270483-03S1R01
    Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study
    $68.6K
    award amount
  • 1R01CA285331-01A1R01
    Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV
    $1
    award amount

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Pennsylvania
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5542
  5. 2024
    Multi-Institutional Research
    Awards at 4 institutions